DCF — KINGMAN REGIONAL MEDICAL CENTER
Enterprise Value: $-382.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-382.2M
Enterprise Value
$-125.8M
PV of Cash Flows
$-256.4M
PV of Terminal Value
$-413.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $384.8M | $-21.1M | -5.0% | $-37.4M | $-34.0M |
| Year 2 | $396.3M | $-17.8M | -4.0% | $-34.6M | $-28.6M |
| Year 3 | $408.2M | $-14.3M | -3.0% | $-31.5M | $-23.7M |
| Year 4 | $420.4M | $-12.6M | -3.0% | $-30.4M | $-20.8M |
| Year 5 | $433.1M | $-11.9M | -3.0% | $-30.2M | $-18.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-382.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$373.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05994460383723418
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5